{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ03026",
      "entity_text" : "VTE risk",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Organ" : [ "uberon:UBERON:0002103" ],
      "Species" : [ "taxonomy:9606" ]
    }
  },
  "verbose_text" : "They advise its use for all patients with any level of VTE risk, both in cases with contraindications against anticoagulants and as an adjuvant to pharmacological treatment.",
  "reading_complete" : "2020-08-04T13:34:33Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T13:33:22Z",
  "trigger" : "level",
  "evidence" : [ "level of VTE risk" ],
  "pmc_id" : "6326129",
  "score" : 0
}